AOD9604 is a Hexadecapeptide originally developed as an analogue of HGH with the express purpose of fighting fat. This peptide is actually a modified version of fragment 176-191, which is itself a small extracted sequence of HGH.
AOD9604 was originally developed as an anti-obesity drug. And this was due to its lipolytic fat burning properties. But surprisingly, this peptide has limited effects beyond fat burning.
Continue reading
